SEC Form 4 · accession 0001193125-26-260084
MiNK Therapeutics, Inc. · INKT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Ryan
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001840229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 4, 2026 | S | 500 | $12.6835 | D | 22,969 | D | |
| Common StockF1 | Jun 4, 2026 | S | 1,000 | $12.7995 | D | 21,969 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.